Buckingham Palace announced that King Charles III has received a cancer diagnosis after undergoing a procedure for an enlarged prostate.

 The specific type of cancer detected remains unknown, but the palace confirmed that Charles does not have prostate cancer.

The procedure involves a transurethral resection, a surgical intervention aimed at eliminating excessive prostate tissue.

The procedure involves the use of a scope through the urethra, a tube equipped with a camera at its tip, to visualize the prostate and accurately identify the location for tissue removal.

Dr. Christian Pavlovich, a professor of urology and oncology at Johns Hopkins School of Medicine, explains that the scope can identify cancer in adjacent regions like the bladder or the urethra.

King Charles It is uncommon to discover cancerous tissue while performing a procedure to treat prostate enlargement.

On Monday, Charles arrived in London to begin treatments for his cancer that are typically administered in outpatient settings.

Benign prostatic hyperplasia (BPH) is prevalent in elderly males and affects approximately 80% of males aged 70 and above.